Validation Study of a Serum-miRNA Signature in Glioma Patients.
Clinical trial NCT06178692 · UNKNOWN
Trial details
- NCT number
- NCT06178692
- Sponsor
- Regina Elena Cancer Institute
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-05-10
- Primary completion
- 2022-11-17
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.